Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-Current Assets: 2023-2025

Historic Non-Current Assets for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $2.2 million.

  • Upstream Bio's Non-Current Assets fell 59.87% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 59.87%. This contributed to the annual value of $2.6 million for FY2024, which is 1166.83% up from last year.
  • Latest data reveals that Upstream Bio reported Non-Current Assets of $2.2 million as of Q3 2025, which was down 3.16% from $2.2 million recorded in Q2 2025.
  • Upstream Bio's Non-Current Assets' 5-year high stood at $5.4 million during Q3 2024, with a 5-year trough of $202,000 in Q4 2023.
  • In the last 3 years, Upstream Bio's Non-Current Assets had a median value of $2.3 million in 2025 and averaged $2.5 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first spiked by 1,166.83% in 2024, then plummeted by 59.87% in 2025.
  • Upstream Bio's Non-Current Assets (Quarterly) stood at $202,000 in 2023, then soared by 1,166.83% to $2.6 million in 2024, then tumbled by 59.87% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.2 million for Q2 2025, and $2.4 million during Q1 2025.